After UnitedHealthcare CEO Brian Thompson was shot to death in December, law enforcement records show a burst of police ...

WASHINGTON, Jan 19 — US health officials announced on Friday that they were awarding US$590 million to Moderna to develop ...

The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to ...

Violence against women For the weekly Donna Moderna, Toscani devised a campaign against violence against women featuring a naked boy and girl next to the words 'executioner' and 'victim'.

The U.S. faces a potential 'Quad-emic' with rising cases of flu, COVID, RSV, and norovirus. Older adults, especially those ...

Emma McIntyre/Getty Images Dolly Parton must work longer than 9 to 5 to balance her music and impressive charitable efforts.

Moderna and the governor’s office didn’t immediately respond ... Please see our republishing guidelines for use of any other photos and graphics. FDA greenlights new COVID vaccine after a summer of ...

In a paradoxical twist ‘The Moderna Exhibition’ suggests that the most relevant ... Bäckström ingeniously muddles up portraits and pictures, leading her actors along a hall of mirrors that reflects ...

Delving into the details, we found 51% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we ...

Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%.

Moderna's stock roared higher on the back of news about potential AI mRNA vaccines. The company also secured a supply contract in Europe. Shares of Moderna are down 90%, and the company has a huge ...

Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence. The maker of vaccines, including the mRNA vaccine for COVID-19 ...